Sushmita Sarker

Delivery of dual miRNA through CD44-targeted mesoporous silica nanoparticles for enhanced and effective triple-negative breast cancer therapy

Manisha Ahir, Priyanka Upadhyay, Avijit Ghosh et al. · Biomaterials Science · 2020 · 92 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

Transferrin-decorated thymoquinone-loaded PEG-PLGA nanoparticles exhibit anticarcinogenic effect in non-small cell lung carcinoma <i>via</i> the modulation of miR-34a and miR-16

Priyanka Upadhyay, Sushmita Sarker, Avijit Ghosh et al. · Biomaterials Science · 2019 · 70 citations

Medicine, Cancer Biology, Oncology +17

Polyethylene Glycol-Mediated Fusion of Extracellular Vesicles with Cationic Liposomes for the Design of Hybrid Delivery Systems

Dipanjan Mukherjee, Debashish Paul, Sushmita Sarker et al. · ACS Applied Bio Materials · 2021 · 44 citations

Life Sciences, Cell Biology, Pharmaceutics +17

Combinatorial therapy of Thymoquinone and Emodin synergistically enhances apoptosis, attenuates cell migration and reduces stemness efficiently in breast cancer

Mousumi Bhattacharjee, Priyanka Upadhyay, Sushmita Sarker et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2020 · 39 citations

Medicine, Oncology, Pharmacology +14

Methylglyoxal at metronomic doses sensitizes breast cancer cells to doxorubicin and cisplatin causing synergistic induction of programmed cell death and inhibition of stemness

Anirban Roy, Sushmita Sarker, Priyanka Upadhyay et al. · Biochemical Pharmacology · 2018 · 24 citations

Medicine, Oncology, Pharmacology +17